Literature DB >> 9875142

Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells.

M G Buckley1, P J Gallagher, A F Walls.   

Abstract

Although there is relatively little evidence of inflammation in osteoarthritis (OA), increases in mast cell numbers and mast cell activation are prominent features of the synovial tissue. As little is known of the types of mast cells which may be involved, the numbers and distribution of mast cell subpopulations have been investigated as defined according to their content of proteases. Tissue was obtained from patients with OA undergoing total knee replacement surgery (n = 14) and from control subjects either post-mortem (n = 11) or following leg amputation for peripheral vascular disease (n = 3); a double-labelling immunocytochemical procedure with monoclonal antibodies specific for tryptase and chymase was applied to identify those mast cells which contain both tryptase and chymase (MCTC) and those with tryptase but not chymase (MCT). There was considerable variation between individual tissues and between sites of tissue sampling, but cells of the MCTC subset were predominant in the synovial layer of both groups of subjects without joint disease, accounting for some 60 per cent of all mast cells present. In tissue from OA patients, however, there appeared to have been a striking shift in the relative proportions of mast cells from the MCTC to the MCT phenotype, with many more MCT cells present in the synovial tissues of OA patients (median 53 MCT/mm2) than in tissue from post-mortem (7.5 MCT/mm2, P < 0.0001) or amputation controls (12 MCT/mm2). In contrast, numbers of synovial MCTC cells in the synovium of OA patients (20 MCTC/mm2) differed little from those in either of the control groups (both 12 MCTC/mm2). In several other conditions, the MCT cells have been linked with inflammatory events, but it seems that in OA, other factors may be operating to induce a selective expansion of this subpopulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875142     DOI: 10.1002/(SICI)1096-9896(199809)186:1<67::AID-PATH132>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

Review 1.  Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.

Authors:  Niamh Fahy; Eric Farrell; Thomas Ritter; Aideen E Ryan; J Mary Murphy
Journal:  Tissue Eng Part B Rev       Date:  2014-08-04       Impact factor: 6.389

2.  Blood cells transcriptomics as source of potential biomarkers of articular health improvement: effects of oral intake of a rooster combs extract rich in hyaluronic acid.

Authors:  Juana Sánchez; M Luisa Bonet; Jaap Keijer; Evert M van Schothorst; Ingrid Mölller; Carles Chetrit; Daniel Martinez-Puig; Andreu Palou
Journal:  Genes Nutr       Date:  2014-07-15       Impact factor: 5.523

Review 3.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens.

Authors:  Natalia J Magarinos; Katherine J Bryant; Amanda J Fosang; Roberto Adachi; Richard L Stevens; H Patrick McNeil
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

Review 5.  Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.

Authors:  William H Robinson; Christin M Lepus; Qian Wang; Harini Raghu; Rong Mao; Tamsin M Lindstrom; Jeremy Sokolove
Journal:  Nat Rev Rheumatol       Date:  2016-08-19       Impact factor: 20.543

6.  Joint capsule mast cells and neuropeptides are increased within four weeks of injury and remain elevated in chronic stages of posttraumatic contractures.

Authors:  Kevin A Hildebrand; Mei Zhang; Paul T Salo; David A Hart
Journal:  J Orthop Res       Date:  2008-10       Impact factor: 3.494

7.  Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.

Authors:  Shunji Nakano; Takuya Mishiro; Shigeyuki Takahara; Hiromichi Yokoi; Daisuke Hamada; Kiminori Yukata; Yoichiro Takata; Tomohiro Goto; Hiroshi Egawa; Susumu Yasuoka; Harumi Furouchi; Katsuya Hirasaka; Takeshi Nikawa; Natsuo Yasui
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 3.650

Review 8.  Recognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis.

Authors:  Adrese M Kandahari; Xinlin Yang; Abhijit S Dighe; Dongfeng Pan; Quanjun Cui
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

9.  Inflammation and its resolution and the musculoskeletal system.

Authors:  Jiri Gallo; Milan Raska; Eva Kriegova; Stuart B Goodman
Journal:  J Orthop Translat       Date:  2017-06-03       Impact factor: 5.191

10.  Possible Regulation of bFGF Expression by Mast Cells in Osteoarthritis Patients with Obesity: A Cross-Sectional Study.

Authors:  Ken Takata; Kentaro Uchida; Shotaro Takano; Manabu Mukai; Gen Inoue; Hiroyuki Sekiguchi; Jun Aikawa; Masayuki Miyagi; Dai Iwase; Masashi Takaso
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-16       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.